Can I read Bone Metastases and Bisphosphonates in mRCC on EtoBox?

Bone Metastases and Bisphosphonates in mRCC by dvixos is a document available to read on EtoBox.

What is Bone Metastases and Bisphosphonates in mRCC about?

This study evaluates the impact of bone metastases and bisphosphonate therapy on patients with metastatic renal cell carcinoma (mRCC). It finds that bone metastases significantly worsen overall survival and progression-free survival, while bisphosphonate therapy does not improve survival rates and is associated with increased adverse events. The analysis involved 2,749 patients and highlights the need for better management of bone metastases in mRCC.

Author

dvixos

Language

EN